-
-
-
-
-
-
-
Vanda Pharmaceuticals (VNDA) PT Lowered to $20 at H.C. Wainwright
-
-
-
-
-
-
-
Vanda Pharmaceuticals (VNDA) Misses Q1 EPS by 13c, provides guidance
-
-
-
-
-
-
-
Truist Securities Starts Vanda Pharmaceuticals (VNDA) at Buy
-
-
-
-
-
-
-
Vanda Pharmaceuticals (VNDA) files $200M mixed shelf
-
-
-
-
-
-
-
Vanda Pharmaceuticals (VNDA) Reiterated at Outperform by Cantor Fitzgerald
-
-
-
-
-
-
-
Vanda Pharmaceuticals (VNDA) 2300 contracts of January 6 calls trade
-
-
-
-
-
-
-
Federal appeals court overturns FDA denial of Vanda's jet lag drug
-
482,472 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


